Potentiation of Chemotherapeutic Agents following Antagonism of Nuclear Factor kappa B in Human Gliomas

Kyle D. Weaver(University of North Carolina at Chapel Hill), Susan Yeyeodu(UNC Lineberger Comprehensive Cancer Center), James C. Cusack(Massachusetts General Hospital), A S Baldwin(UNC Lineberger Comprehensive Cancer Center), Matthew G. Ewend(UNC Lineberger Comprehensive Cancer Center)
Journal of Neuro-Oncology
February 1, 2003
10.1023/a:1022554824129
Cited by 93

Abstract

Related Papers

TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Cun-Yu Wang, Marty W. Mayo, Albert S. Baldwin|Science|1996|2.6k
Suppression of TNF-α-Induced Apoptosis by NF-κB
Daniel J. Van Antwerp, Séamus J. Martin, Tal Kafri et al.|Science|1996|2.6k
Osteopetrosis in mice lacking NF-κB1 and NF-κB2
Violetta Iotsova, Jorge Caamaño, James Loy et al.|Nature Medicine|1997|995
Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
Cun-Yu Wang, James C. Cusack, Rong Liu et al.|Nature Medicine|1999|994
Requirement for NF-κB in osteoclast and B-cell development
Guido Franzoso, Louise Carlson, Lianping Xing et al.|Genes & Development|1997|993